Association of polymorphisms in the beta-2 and beta-3 adrenoceptor genes with risk of colorectal cancer in Japanese

被引:29
作者
Takezaki T. [1 ]
Hamajima N. [1 ]
Matsuo K. [1 ,2 ]
Tanaka R. [3 ]
Hirai T. [4 ]
Kato T. [4 ]
Ohashi K. [5 ]
Tajima K. [1 ]
机构
[1] Division of Epidemiology and Prevention, Aichi Cancer Center, Research Institute, Chikusa-ku, Nagoya 464-8681
[2] Nagoya University, Graduate School of Medicine, Nagoya
[3] Department of Clinical Laboratories, Aichi Cancer Center Hospital, Nagoya
[4] Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya
[5] Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya
关键词
Beta-2; adrenoceptor; Beta-3; Colorectal cancer; Polymorphism;
D O I
10.1007/PL00012092
中图分类号
学科分类号
摘要
Background. The adrenergic receptor system is involved in thermogenesis and in the activation of lipid mobilization in fat cells, and polymorphisms in the beta-2 and beta-3 adrenoceptor genes (BAR2 and BAR3) have been reported to be associated with obesity and insulin resistance. To examine links between polymorphisms in these genes and the risk of colorectal cancer in Japanese, we conducted the present hospital-based case-referent study. Methods. Mutations of the BAR2 gene at codon 27 (Gln27Glu) and of the BAR3 gene at codon 64 (Trp64Arg) were examined in 131 patients with colorectal cancer (cases) and in 239 cancer-free referents. We also collected information on environmental factors, using a questionnaire approach. Odds ratios (ORs) were estimated with an unconditional logistic model, after adjustment for potential confounding factors. Results. The proportional distribution of the mutations in BAR2 and BAR3 did not differ between cases and referents. Analysis of a subgroup with a higher body mass index showed that the Trp64Arg variant increased the OR (2.63; 95% confidence interval, 1.13-6.11) for colon cancer, but not for rectal cancer, compared with the Trp64 geno-type. Altered ORs for colon and rectal cancers with the Gln27Glu variant were not observed in either the subgroup with the lower body mass index or the subgroup with the higher body mass index. Conclusion. These findings suggest that the BAR3 polymorphism may alter the susceptibility to colon cancer risk in obese subjects. To confirm this finding, a further study with a larger number of subjects is now required.
引用
收藏
页码:117 / 122
页数:5
相关论文
共 25 条
  • [1] Arner P., Hoffstedt J., Adrenoceptor genes in human obesity, J Intern Med, 245, pp. 667-672, (1999)
  • [2] Enocksson S., Shimizu M., Lonnqvist F., Et al., Demonstration of an in vivo functional beta 3-adrenoceptor in man, J Clin Invest, 95, pp. 2239-2245, (1995)
  • [3] Emorine L.J., Marullo S., Briend Sutren M.M., Et al., Molecular characterization of the human beta 3-adrenergic receptor, Science, 245, pp. 1118-1121, (1989)
  • [4] Green S.A., Turki J., Hall I.P., Et al., Implications of genetic variability of human beta 2-adrenergic receptor structure, Pulm Pharmacol, 8, pp. 1-10, (1995)
  • [5] Large V., Hellstrom L., Reynisdottir S., Et al., Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function, J Clin Invest, 100, pp. 3005-3013, (1997)
  • [6] Sakane N., Yoshida T., Umekawa T., Et al., Beta2-adrenoceptor gene polymorphism and obesity, Lancet, 353, (1999)
  • [7] Clement K., Vaisse C., Manning B.S., Et al., Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity, N Engl J Med, 333, pp. 352-354, (1995)
  • [8] Widen E., Lehto M., Kanninen T., Et al., Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns, N Engl J Med, 333, pp. 348-351, (1995)
  • [9] Walston J., Silver K., Bogardus C., Et al., Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene, N Engl J Med, 333, pp. 343-347, (1995)
  • [10] Colon, rectum, pp. 216-251, (1997)